Log on / register
Feedback | Support | My details
Brca1 breast tumors contain distinct CD44+/CD24- and CD133+ cells with cancer stem cell characteristics.
Wright MH, Calcagno AM, Salcido CD, Carlson MD, Ambudkar SV, Varticovski L
Breast Cancer Res 2008, 10:R10
[Full text] [PubMed] [Related articles] [Cited on BioMed Central]


printer friendly 
to  [Help]

PubMed Central articles that cite the above article:

1.
Identification and characterization of cancer initiating cells from BRCA1 related mammary tumors using markers for normal mammary stem cells.
Vassilopoulos A, Wang RH, Petrovas C, Ambrozak D, Koup R, Deng CX
Int J Biol Sci 2008, 4:133-42
 [PubMed Central] [PubMed] [Related articles]
2.
Natural product inhibitors of Hsp90: potential leads for drug discovery.
Amolins MW, Blagg BS
Mini Rev Med Chem 2009 Feb, 9:140-52
 [PubMed Central] [PubMed] [Related articles]

This article is also cited by 7 articles in BioMed Central


You can also check ISI Web of Science for additional citations (subscription required)
printer friendly 
to  [Help]
Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.